The company is pursuing financing for the trials needed for the FDA approval of S26 in the treatment of Alzheimer's Disease.

We were pleasantly surprised to be contacted recently by Nick Shulman, Senior Producer of "Discoveries Today" with Daymon John, on Bloomberg TV.

Their Research Department was impressed by Septa's innovative approcach to developing next-generation therapeutic solutions, and expressed an interest in highlighting Septa in an upcoming quarterly episode.